Phibro Animal Health Stock Probability Of Bankruptcy

PAHC Stock

USD 23.54 0.17 0.73%

Phibro Animal's odds of distress is under 8% at the present time. It has tiny probability of undergoing some form of financial straits in the near future. Probability of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Phibro balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Phibro Animal Piotroski F Score and Phibro Animal Altman Z Score analysis.

Phibro Animal Health Company probability of distress Analysis

Phibro Animal's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Phibro Animal Probability Of Bankruptcy

Less than 8%

Most of Phibro Animal's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Phibro Animal probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Phibro Animal odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Phibro Animal Health financial health.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.94)

Dividend Share

0.48

Earnings Share

0.43

Revenue Per Share

25.843

Quarterly Revenue Growth

0.126

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.87	0.8	0.82	0.52	0.95	0.89	0.99	0.8	0.78	-0.13	0.96	0.95	0.79	0.0	0.73	0.26	-0.69	0.73	0.78	0.86	0.82	0.82	-0.09
Total Stockholder Equity	0.81		0.53	0.98	0.54	0.24	0.84	0.54	0.8	0.79	0.65	-0.55	0.76	0.87	0.94	-0.1	0.75	0.34	-0.79	0.54	0.84	0.93	0.82	0.83	-0.39
Net Debt	0.87	0.53		0.55	0.78	0.76	0.72	0.97	0.87	0.72	0.6	0.19	0.88	0.82	0.58	-0.03	0.59	0.02	-0.39	0.83	0.66	0.64	0.79	0.76	-0.14
Retained Earnings	0.8	0.98	0.55		0.52	0.33	0.79	0.54	0.78	0.85	0.6	-0.51	0.76	0.87	0.93	-0.12	0.77	0.26	-0.73	0.61	0.87	0.92	0.86	0.86	-0.42
Accounts Payable	0.82	0.54	0.78	0.52		0.54	0.81	0.88	0.86	0.56	0.54	0.17	0.72	0.7	0.62	-0.24	0.39	0.19	-0.47	0.59	0.64	0.58	0.7	0.71	-0.15
Long Term Debt	0.52	0.24	0.76	0.33	0.54		0.36	0.69	0.54	0.62	0.15	0.27	0.61	0.57	0.33	-0.05	0.38	-0.47	0.17	0.81	0.51	0.27	0.68	0.63	-0.16
Net Receivables	0.95	0.84	0.72	0.79	0.81	0.36		0.77	0.96	0.73	0.68	-0.24	0.87	0.85	0.82	-0.04	0.63	0.29	-0.69	0.57	0.76	0.83	0.78	0.81	-0.09
Total Liab	0.89	0.54	0.97	0.54	0.88	0.69	0.77		0.9	0.65	0.64	0.27	0.86	0.8	0.61	-0.07	0.55	0.11	-0.47	0.74	0.67	0.65	0.74	0.73	-0.15
Total Current Assets	0.99	0.8	0.87	0.78	0.86	0.54	0.96	0.9		0.8	0.72	-0.07	0.94	0.92	0.81	-0.04	0.71	0.25	-0.66	0.71	0.8	0.83	0.84	0.84	-0.12
Short Term Debt	0.8	0.79	0.72	0.85	0.56	0.62	0.73	0.65	0.8		0.4	-0.37	0.86	0.85	0.8	-0.12	0.79	0.04	-0.46	0.85	0.9	0.76	0.92	0.9	-0.36
Intangible Assets	0.78	0.65	0.6	0.6	0.54	0.15	0.68	0.64	0.72	0.4		-0.11	0.68	0.78	0.49	0.16	0.59	0.4	-0.79	0.37	0.42	0.75	0.41	0.39	0.14
Common Stock	-0.13	-0.55	0.19	-0.51	0.17	0.27	-0.24	0.27	-0.07	-0.37	-0.11		-0.16	-0.26	-0.35	0.08	-0.26	-0.26	0.39	-0.16	-0.31	-0.36	-0.26	-0.26	0.22
Property Plant Equipment	0.96	0.76	0.88	0.76	0.72	0.61	0.87	0.86	0.94	0.86	0.68	-0.16		0.94	0.75	0.04	0.76	0.17	-0.59	0.83	0.83	0.81	0.83	0.81	-0.16
Good Will	0.95	0.87	0.82	0.87	0.7	0.57	0.85	0.8	0.92	0.85	0.78	-0.26	0.94		0.8	-0.01	0.8	0.22	-0.68	0.8	0.83	0.87	0.86	0.83	-0.2
Net Tangible Assets	0.79	0.94	0.58	0.93	0.62	0.33	0.82	0.61	0.81	0.8	0.49	-0.35	0.75	0.8		-0.23	0.71	0.27	-0.68	0.54	0.91	0.89	0.87	0.9	-0.57
Current Deferred Revenue	0.0	-0.1	-0.03	-0.12	-0.24	-0.05	-0.04	-0.07	-0.04	-0.12	0.16	0.08	0.04	-0.01	-0.23		-0.04	0.05	-0.01	-0.09	-0.3	-0.08	-0.19	-0.18	0.54
Short Term Investments	0.73	0.75	0.59	0.77	0.39	0.38	0.63	0.55	0.71	0.79	0.59	-0.26	0.76	0.8	0.71	-0.04		0.15	-0.57	0.57	0.78	0.75	0.66	0.64	-0.23
Deferred Long Term Liab	0.26	0.34	0.02	0.26	0.19	-0.47	0.29	0.11	0.25	0.04	0.4	-0.26	0.17	0.22	0.27	0.05	0.15		-0.74	-0.04	0.13	0.25	0.07	0.09	-0.01
Short Long Term Debt	-0.69	-0.79	-0.39	-0.73	-0.47	0.17	-0.69	-0.47	-0.66	-0.46	-0.79	0.39	-0.59	-0.68	-0.68	-0.01	-0.57	-0.74		-0.28	-0.55	-0.8	-0.47	-0.48	0.17
Long Term Debt Total	0.73	0.54	0.83	0.61	0.59	0.81	0.57	0.74	0.71	0.85	0.37	-0.16	0.83	0.8	0.54	-0.09	0.57	-0.04	-0.28		0.73	0.55	0.85	0.79	-0.28
Capital Surpluse	0.78	0.84	0.66	0.87	0.64	0.51	0.76	0.67	0.8	0.9	0.42	-0.31	0.83	0.83	0.91	-0.3	0.78	0.13	-0.55	0.73		0.82	0.88	0.88	-0.6
Long Term Investments	0.86	0.93	0.64	0.92	0.58	0.27	0.83	0.65	0.83	0.76	0.75	-0.36	0.81	0.87	0.89	-0.08	0.75	0.25	-0.8	0.55	0.82		0.76	0.77	-0.36
Net Invested Capital	0.82	0.82	0.79	0.86	0.7	0.68	0.78	0.74	0.84	0.92	0.41	-0.26	0.83	0.86	0.87	-0.19	0.66	0.07	-0.47	0.85	0.88	0.76		0.99	-0.48
Net Working Capital	0.82	0.83	0.76	0.86	0.71	0.63	0.81	0.73	0.84	0.9	0.39	-0.26	0.81	0.83	0.9	-0.18	0.64	0.09	-0.48	0.79	0.88	0.77	0.99		-0.47
Capital Stock	-0.09	-0.39	-0.14	-0.42	-0.15	-0.16	-0.09	-0.15	-0.12	-0.36	0.14	0.22	-0.16	-0.2	-0.57	0.54	-0.23	-0.01	0.17	-0.28	-0.6	-0.36	-0.48	-0.47

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.0428	0.0646	0.0528	0.0336	0.00246	0.002337
Asset Turnover	1.14	1.02	0.99	1.01	1.04	1.39
Net Debt	374.4M	376.5M	396.2M	468.7M	454.8M	301.8M
Total Current Liabilities	157.2M	164.1M	190.8M	176M	204.1M	141.8M
Non Current Liabilities Total	438.7M	438.7M	478.4M	512.9M	521.4M	369.7M
Total Assets	784.1M	841.3M	931.7M	971.4M	982.2M	568.4M
Total Current Assets	451.8M	498.9M	566.2M	585.7M	601.0M	362.1M
Total Cash From Operating Activities	59.3M	48.3M	31.6M	13.3M	87.6M	92.0M

	Return On Equity	0.0655
	Return On Asset	0.0526
	Profit Margin	0.02 %
	Operating Margin	0.08 %
	Current Valuation	1.37 B
	Shares Outstanding	20.34 M
	Shares Owned By Insiders	0.57 %
	Shares Owned By Institutions	99.43 %
	Number Of Shares Shorted	463.35 K
	Price To Earning	11.39 X
	Price To Book	3.66 X
	Price To Sales	0.91 X
	Revenue	1.02 B
	Gross Profit	298.24 M
	EBITDA	84.61 M
	Net Income	2.42 M
	Cash And Equivalents	98.67 M
	Cash Per Share	2.44 X
	Total Debt	525.46 M
	Debt To Equity	1.79 %
	Current Ratio	2.97 X
	Book Value Per Share	6.38 X
	Cash Flow From Operations	87.59 M
	Short Ratio	2.58 X
	Earnings Per Share	0.43 X
	Price To Earnings To Growth	1.66 X
	Target Price	18.4
	Number Of Employees	1.94 K
	Beta	0.51
	Market Capitalization	955.48 M
	Total Asset	982.18 M
	Retained Earnings	243.89 M
	Working Capital	396.85 M
	Current Asset	342.83 M
	Current Liabilities	108.78 M
	Annual Yield	0.02 %
	Five Year Return	1.85 %
	Net Asset	982.18 M
	Last Dividend Paid	0.48

Phibro Animal Health Stock Probability Of Bankruptcy

Phibro Animal Health Company probability of distress Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Phibro Animal Probability Of Bankruptcy

Phibro Probability Of Bankruptcy Driver Correlations

Phibro Probability Of Bankruptcy Peer Comparison

Phibro Animal Main Bankruptcy Drivers

Phibro Animal ESG Sustainability

Phibro Fundamentals

About Phibro Animal Fundamental Analysis

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY